AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print May 30, 2006
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2005.071332v1
96/7/1219    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, G.
Right arrow Articles by Kuh, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, G.
Right arrow Articles by Kuh, D.
Related Collections
Right arrow Media
Right arrow Health Education
Right arrow Public Health Practice
Right arrow Socioeconomic Factors
Right arrow Women's Health
Right arrow Cardiovascular Disease
July 2006, Vol 96, No. 7 | American Journal of Public Health 1219-1225
© 2006 American Public Health Association
DOI: 10.2105/AJPH.2005.071332


RESEARCH AND PRACTICE

Cessation of Hormone Replacement Therapy After Reports of Adverse Findings From Randomized Controlled Trials: Evidence From a British Birth Cohort

Gita Mishra, PhD, Helen Kok, PhD, Russell Ecob, MSc, Rachel Cooper, MSc, Rebecca Hardy, PhD and Diana Kuh, PhD

Gita Mishra, Rachel Cooper, Rebecca Hardy, and Diana Kuh are with the MRC National Survey of Health and Development, Department of Epidemiology and Public Health, Royal Free and University College Medical School, London, England. At the time of the study, Helen Kok was with the Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands. Russell Ecob is with the MRC Hearing and Communications Research Group, University of Manchester, UK.

Correspondence: Requests for reprints should be sent to Professor Diana Kuh, MRC National Survey of Health and Development, Department of Epidemiology and Public Health, Royal Free and University College London Medical School, Gower Street Campus, 1–19 Torrington Place, London WC1E 6BT (e-mail: d.kuh{at}nshd.mrc.ac.uk).

Objectives. We examined the cessation of hormone replacement therapy (HRT) among British women, by educational level, social class, and cardiovascular risk factors, at the time of publicity about 2 clinical trials of HRT that were halted after adverse findings.

Methods. A total of 1387 women aged 57 years reported their monthly HRT use between January 2002 and February 2003. A succession of regression-based time-series models were fitted to detect changes in the proportion of HRT users stratified by education level, social class, hypertension, and obesity.

Results. The overall percentage of HRT users declined from 31% in January 2002 to less than 26% by February 2003. Changes in trends of HRT use were first detected in June 2002 (for women with advanced secondary educational qualification or higher) and in July 2002 (for all other groups). The rate of decline was greatest for women with no formal educational qualifications, from the manual social class, or who were hypertensive or obese.

Conclusions. These decreases coincided with the announced cessation of a large US clinical trial of HRT. This publicity may have had a differential influence on the immediate decline in HRT use by various groups of British women.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Public Health Association